These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 15958770)
1. Production of anti-CCP antibodies and matrix metalloproteinase-3 by human rheumatoid arthritis synovial tissues using SCID mice. Iwaki-Egawa S; Matsuno H; Ogawa Y; Watanabe Y Ann Rheum Dis; 2005 Jul; 64(7):1094-5. PubMed ID: 15958770 [No Abstract] [Full Text] [Related]
2. Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model. Matsuno H; Sawai T; Nezuka T; Uzuki M; Tsuji H; Nishimoto N; Yoshizaki K Arthritis Rheum; 1998 Nov; 41(11):2014-21. PubMed ID: 9811057 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694 [TBL] [Abstract][Full Text] [Related]
4. Anti-citrullinated protein antibody response associated with synovial immune deposits in a patient with suspected early rheumatoid arthritis. Willemze A; Ioan-Facsinay A; El-Gabalawy H J Rheumatol; 2008 Nov; 35(11):2282-4. PubMed ID: 19004060 [No Abstract] [Full Text] [Related]
5. Systemic characteristics of chronic arthritis induced by transfer of human rheumatoid synovial membrane into SCID mice (human/murine SCID arthritis). Sack U; Günther A; Pfeiffer R; Genest M; Kinne J; Biskop M; Kämpfer I; Krenn V; Emmrich F; Lehmann J J Autoimmun; 1999 Nov; 13(3):335-46. PubMed ID: 10550221 [TBL] [Abstract][Full Text] [Related]
6. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. van Oosterhout M; Bajema I; Levarht EW; Toes RE; Huizinga TW; van Laar JM Arthritis Rheum; 2008 Jan; 58(1):53-60. PubMed ID: 18163491 [TBL] [Abstract][Full Text] [Related]
7. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Zendman AJ; van Venrooij WJ; Pruijn GJ Rheumatology (Oxford); 2006 Jan; 45(1):20-5. PubMed ID: 16188946 [No Abstract] [Full Text] [Related]
8. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412 [TBL] [Abstract][Full Text] [Related]
9. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of CD147/HAb18 monoclonal antibody on cartilage erosion and synovitis in the SCID mouse model for rheumatoid arthritis. Jia J; Wang C; Shi Z; Zhao J; Jia Y; Zhao-Hui Z; Li X; Chen Z; Zhu P Rheumatology (Oxford); 2009 Jul; 48(7):721-6. PubMed ID: 19429906 [TBL] [Abstract][Full Text] [Related]
11. Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Inui N; Enomoto N; Suda T; Kageyama Y; Watanabe H; Chida K Clin Biochem; 2008 Sep; 41(13):1074-7. PubMed ID: 18638466 [TBL] [Abstract][Full Text] [Related]
12. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review. Lee AN; Beck CE; Hall M Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856 [TBL] [Abstract][Full Text] [Related]
14. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis. van Venrooij WJ; van Beers JJ; Pruijn GJ Ann N Y Acad Sci; 2008 Nov; 1143():268-85. PubMed ID: 19076355 [TBL] [Abstract][Full Text] [Related]
15. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis]. Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426 [TBL] [Abstract][Full Text] [Related]
16. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Huizinga TW; Toes RE; de Vries RR Arthritis Rheum; 2006 Apr; 54(4):1117-21. PubMed ID: 16572446 [TBL] [Abstract][Full Text] [Related]
17. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Korkmaz C; Us T; Kaşifoğlu T; Akgün Y Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149 [TBL] [Abstract][Full Text] [Related]
18. Retroviral gene transfer of an antisense construct against membrane type 1 matrix metalloproteinase reduces the invasiveness of rheumatoid arthritis synovial fibroblasts. Rutkauskaite E; Volkmer D; Shigeyama Y; Schedel J; Pap G; Müller-Ladner U; Meinecke I; Alexander D; Gay RE; Drynda S; Neumann W; Michel BA; Aicher WK; Gay S; Pap T Arthritis Rheum; 2005 Jul; 52(7):2010-4. PubMed ID: 15986375 [TBL] [Abstract][Full Text] [Related]
19. Absence of citrulline-specific autoantibodies in animal models of autoimmunity. Vossenaar ER; van Boekel MA; van Venrooij WJ; López-Hoyoz M; Merino J; Merino R; Joosten LA Arthritis Rheum; 2004 Jul; 50(7):2370-2. PubMed ID: 15248238 [No Abstract] [Full Text] [Related]
20. Cyclophilins in rheumatoid arthritis--stepping into an undiscovered country? Pap T Clin Immunol; 2005 Sep; 116(3):199-201. PubMed ID: 16039162 [No Abstract] [Full Text] [Related] [Next] [New Search]